Clinical Trial Update: A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies [Phase 1]

View source ↗

Summary

A Phase I study of an alloreactive cell infusion following transplantation of haplotype cells in patients with myeloid malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoid | Phase 1 | Status: TERMINATED